Apotex reports Q2 profit, raises guidance for revenue growth for the year

Summary

• Apotex Health Corp. reported a second-quarter profit of $100.8 million, an increase from $82.9 million in the prior year.
• The company raised its full-year revenue growth guidance to 9-10%, up from previous expectations of 7-8%.
• Full-year adjusted EBITDA margin guidance was increased to approximately 31%, compared to an earlier forecast of 30%.
• Quarterly revenue reached $852.9 million, up from $843.5 million in the same period last year.
• Reported diluted earnings per share were 41 cents, while adjusted diluted earnings per share were 57 cents for the quarter.